Sponsor pipeline

China Immunotech (Beijing) Biotechnology Co., Ltd. clinical trial pipeline

Get alerts when China Immunotech (Beijing) Biotechnology Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
6

Disease areas by active trials

Lupus (SLE) (5) · Scleroderma (3) · Rheumatoid Arthritis (1)

Get alerts when China Immunotech (Beijing) Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free